Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

Despite the considerable progress in understanding the molecular bases of acute myeloid leukemia (AML), new tools to link disease biology to the unpredictable patient clinical course are still needed. Herein, high-throughput metabolomics, combined with the other “-omics” disciplines, holds promise i...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrabba, Matteo G., Tavel, Laurette, Oliveira, Giacomo, Forcina, Alessandra, Quilici, Giacomo, Nardelli, Francesca, Tresoldi, Cristina, Ambrosi, Alessandro, Ciceri, Fabio, Bernardi, Massimo, Vago, Luca, Musco, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086061/
https://www.ncbi.nlm.nih.gov/pubmed/27793157
http://dx.doi.org/10.1186/s13045-016-0346-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086061/
https://www.ncbi.nlm.nih.gov/pubmed/27793157
http://dx.doi.org/10.1186/s13045-016-0346-2

Ejemplares similares